Cartesian Therapeutics, Inc.: cash_and_restricted_cash
| Value | {"amount": 80980000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2023-09-30) |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ecb2c3b4-3a6f-45c9-814d-56cfa3e8f50f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-23-276086Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/cash-and-restricted-cash/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ecb2c3b4-3a6f-45c9-814d-56cfa3e8f50f
History
- no predecessors — first report